Skip to main content
Enlyte Logo
  • Referrals
  • Pharmacy Locator
  • Find a Genex Provider
  • Find a Coventry Provider
  • Enlyte360
  • APD Solutions
  • Casualty Solutions
    • Solutions
      • Cost Containment Services
        • Medical Bill Review
          • Bill Audit
          • Electronic Payments
          • Negotiations
          • Regulatory Reporting
          • Specialty Bill Review
        • Injury & Liability
          • Bodily Injury Integrated Solutions
          • Demand Package Review
          • Injury Evaluation
          • Medical Records Summarization
      • Injury Management
        • Case Management
          • Field Case Management
          • Telephonic Case Management
          • Catastrophic Case Management/Crisis Response
          • Vocational Case Management
          • Ergonomics and Physical Demands
          • Alternative Transitional Duty
        • Medicare Set-Aside
        • Nurse Triage
        • Utilization Review
      • Network Management
        • Broad-Based Networks
        • Outcomes-Based Network
        • State-Certified Managed Care Plans
      • Pharmacy Benefit Management
        • Clinical Pharmacy Management
        • Pharmacy Intervention
      • Specialty Services
        • Diagnostics
        • Durable Medical Equipment
        • Home Health Care
        • Orthotics and Prosthetics
        • Physical Medicine
        • Translation
        • Transportation
        • Additional Services
  • Disability Solutions
    • Solutions
      • Manage Disability and Absence
        • Short-term and Long-term Disability
        • Absence Management for Payers
        • STD and ADAAA Services for Employers
      • Social Security and Disability
        • Carrier and Self Insured
        • Disabled Individuals
          • Social Security Team
          • Social Security Lookup
          • Social Security Training
        • Medicare Counseling Services
        • Ticket to Work
  • Tools
    • Solutions
      • Adjusters
        • Enlyte360
        • Locations
        • Make a Referral
        • Resource Hub
      • Clients
        • Enlyte Portal
        • Find a Provider
        • Client Specific Networks
        • Customer Reporting
        • ScriptAdvisor Resources
      • Providers
        • Apricus Provider Resources
        • Coventry Provider Resources
          • Provider Portal
      • Injured/Disabled Individuals
        • Pharmacy Locator
        • Social Security Lookup
        • My Account
  • Insights
    • CE Webinars
    • Events
    • Regulatory & Compliance
    • Trend Reports
    • More Expert Insights ›
  • About Enlyte
    • Values and Culture
    • Leadership
    • News
    • Careers
  • Home
  • Insights
  • Workers' Comp
  • Events
  • Work Comp: COVID-19 Effects and Lasting Impacts [Podcast]
Workers' Comp

Work Comp: COVID-19 Effects and Lasting Impacts [Podcast]

Event Details

Start: April 27, 2020 @ 8:00PM EDT End: @ Location: Online Event

In this podcast series, Mitchell | Genex subject matter experts from across the business share their expertise on how the COVID-19 pandemic is affecting—and will continue to influence—many different areas of the workers’ compensation claims process. Listen below to hear from Mitchell | Genex leaders across our Pharmacy, Casualty Solutions and Genex divisions discussing regulatory changes, the potential impact of delayed care, case management, pharmacy issues and more.

Dr. Mitch Freeman—Mitchell Senior Vice President and Chief Clinical Officer

Dr. Mitch Freeman provides insights into how COVID-19 is impacting pharmacy care for injured workers. Throughout the pandemic, the pharmacy-related impact for the workers' compensation industry has so far been relatively low as pharmacies have remained open, but some medications have been relatively difficult to obtain. One area that has grown in relevance, according to Dr. Freeman, is medication mail order. “I think the best way that we can ensure that we are helping to keep patients safe,” he said, “is to identify patients that might be at risk and to reach out proactively and offer mail order as an alternative to going into a pharmacy and perhaps being exposed to the virus.”

Michele Hibbert-Iacobacci—Mitchell Senior Vice President of Regulatory Compliance Management

Michele Hibbert-Iacboacci shares information about the changes the workers’ compensation industry is seeing as a result of the COVID-19 pandemic specifically related to regulatory updates, increased growth in telemedicine use and presumptions for front-line workers who may contract the virus. She also explains how legislative changes and delayed care for injured workers might leave a lasting impact on the industry. “From a legislative perspective, there is going to be a whole lot more activity on telehealth and telemedicine to make things more permanent,” she said. “A lot of the legislation we’re seeing is emergency and it has a timeline on it, 60-90 days. I believe a lot of that will become permanent. There will be a little bit more investigative work done into it to see if it is the right thing to do in the scope of practices for the providers. Did we do the right thing when we implemented those emergency regulations?”

Pat Chavanu—Genex Senior Vice President of National Accounts and Marketing

Pat Chavanu explores how COVID-19 is affecting access to care for injured employees and how case managers are using their critical thinking skills to facilitate recovery, leveraging telemedicine, educating injured employees on home exercise programs and continuing their services through other traditional and non-traditional methods. This includes limiting potential for delayed return-to-work and helping injured employees navigate their care plans. “Because of the shelter-in policies in many states, some injured workers have either opted to delay treatment or can’t receive treatment due to provider availability,” he said. “Once the shelter-in restrictions have been lifted, I think you’re going to see pent up demand for treatment which could cause delays in provider scheduling, and this could extend claims and claims duration so it could be a problem. To combat this claims duration issue, the best approach is to utilize your clinical resources that are available. Especially in times like this, I feel like the case manager plays an extraordinarily important role in assisting the injured worker and navigating the healthcare system." Learn More

More stories

Workers' Comp Article

New York Provides Data-Backed Proof That Stronger Utilization Review is a Cost-Control Strategy

March 4, 2026

Read how New York's strategic utilization review expansion kept medical payments stable despite rising costs nationwide.

Workers' Comp Article

Settling Future Medical? Don’t Let Medicare Turn It Into a Reopen

March 4, 2026

Discover how to prevent Medicare from disrupting your settled claims. Learn when MSAs are needed, what documentation to gather upfront, and strategic approaches to identify cost drivers.

Business Insurance In the News

What a rise in older workers means for comp

March 3, 2026

As the workforce ages, workers’ comp claims grow more complex. Enlyte experts share insights on case management, ergonomics, and return to work strategies.

Workers' Comp Article

Ask The Pharmacist: The Hidden Risks of Gabapentin in Workers’ Compensation

March 2, 2026

Gabapentin was approved by the Food and Drug Administration (FDA) decades ago for seizures and nerve pain. Today, it is one of the most commonly prescribed drugs in the United States.

Mitchell Article

Plugged-In: EV Collision Insights 2025 Year in Review

February 19, 2026

After several years of steady growth, the battery electric vehicle (BEV) market experienced significant volatility in 2025. Automotive manufacturers scaled back investments—including Ford with its F-150 Lightning end of production announcement—and the U.S. and Canada rescinded tax credits designed to boost consumer demand for BEVs. While brands like GM, Honda and Volkswagen experienced modest BEV sales gains, overall adoption slowed. In the U.S., BEV purchases declined by approximately 2% from 2024 and with more electrified alternatives, Tesla’s market share also dropped to 46.2% from 48.7% in 2024.

Mitchell News Release

Electric Vehicle Collision Claims Rise 14% in the U.S. and 24% in Canada Even as Sales of New Models Slow

February 19, 2026

Mitchell published its latest Plugged-In: EV Collision Insights report today. This issue provides an overview of the most notable 2025 trends in collision claims and repair for battery electric vehicles (BEVs), plug-in hybrid electric vehicles (PHEVs) and mild hybrid electric vehicles (MHEVs). While sales of new BEVs decreased approximately 2% in the U.S., claims for repairable vehicles kept climbing.

  • Load More
Enlyte Logo
  • Media
  • Careers
  • Contact Us

Mitchell

Genex

Coventry

Apricus

twitter X social media icon twitter LinkedIn social media icon twitter YouTube social media icon

©2026 Enlyte Group, LLC. All rights reserved.

Terms of Use

Privacy Practices

Minnesota Rehabilitation Services

Verisys

California Privacy Rights